Viewing nowCombinationDucal Tablet 60/5 mg
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.

MFDS item code 202300097 · Approved 2023.01.06 · Insurance code 647304490
Improvement in blood pressure control for essential hypertension
Pimasartan potassium is used in the treatment of essential hypertension and can be used as an adjunct therapy when blood pressure is not adequately controlled with monotherapy, helping to manage blood pressure more effectively.
The recommended adult dosage is 1 tablet once daily, taken with water regardless of meals. It is advisable to take it at the same time each day (e.g., morning). For patients whose blood pressure is not well controlled on a dose of 30 mg of Pimasartan alone, the 30/2.5 mg dosage can be administered. For patients not adequately controlled on 60 mg of Pimasartan alone, the 60/2.5 mg dosage can be given.
Safety and efficacy for paediatric patients under age 18 have not been established.
This medication may pose a risk of serious harm or death to the fetus and newborn if taken during pregnancy, particularly in the second and third trimesters. Discontinue immediately if pregnancy is confirmed. Do not take this medication if you are allergic to any of the active ingredients or similar substances, if you are pregnant or nursing, if you are undergoing kidney dialysis, have moderate to severe liver disease, bile duct obstruction, specific kidney issues in diabetic patients, certain hereditary lactose intolerance, severe aortic stenosis, or in shock state. Patients with reduced blood volume or sodium levels, impaired kidney function, renal artery hypertension, aortic or mitral stenosis, primary aldosteronism, severe hypotension, elderly patients, and those allergic to specific pigments should exercise caution while using this medication. During treatment, side effects like dizziness, headaches, facial or peripheral edema, urinary disorders, insomnia, and flushing may occur; consult healthcare professionals if symptoms are severe or persistent. Regular blood tests and monitoring are needed due to possible hypotension, electrolyte imbalances, especially increased potassium levels. When combined with other antihypertensive medications, the blood pressure-lowering effect may increase or side effects may occur; inform healthcare professionals about other medications being taken. If you are pregnant or planning to become pregnant, consult healthcare professionals before taking this medication, and the same applies if you are breastfeeding. The safety and efficacy in children and adolescents under age 18 have not been established, so it is advisable not to use it. In the event of overdose, serious symptoms such as hypotension and cardiac arrhythmias may occur, requiring immediate emergency treatment. Store this medication out of reach of children and avoid transferring it to other containers to maintain quality and safety.
Urticaria, severe swelling (edema), difficulty breathing, cold sweat, skin shedding, pain of oral/ocular mucosa, yellowing of skin or eyes (jaundice), extreme fatigue, sudden and severe headache, seizures, confusion, visual disturbances, paralysis, significant reduction in urine output, severe overall swelling accompanied by increased blood pressure, severe allergic reactions, severe skin adverse reactions, respiratory issues, liver abnormalities (jaundice),
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that prevents light exposure. It is also recommended to store the medication at room temperature between 1 to 30 degrees Celsius to maintain its effectiveness.
Orange, rounded square film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.